Prevalence and Rate of Resolution of Left Atrial Thrombus in Patients with Non-Valvular Atrial Fibrillation: A Two-Center Retrospective Real-World Study.
Pompilio FaggianoElisabetta DinatoloAntonella MoreoBenedetta De ChiaraMarco SbolliFrancesco MuscaAntonio CurnisOriana BelliCristina GiannattasioCesare TomasiMarco MetraGloria SantangeloPublished in: Journal of clinical medicine (2022)
= 0.35). Thus, NOACs were demonstrated to be at least as effective as other anticoagulants in the rate of LAA thrombus resolution. Upon multivariate-adjusted analysis, higher LAA emptying velocities were the only predictor of thrombus resolution. In conclusion, the majority of patients were already on anticoagulants. NOACs could be at least as effective as other anticoagulants, yielding an LAA thrombus resolution in two-thirds of patients. This may have clinical relevance, especially in patients undergoing cardioversion or catheter ablation.
Keyphrases
- atrial fibrillation
- left atrial
- catheter ablation
- oral anticoagulants
- end stage renal disease
- patients undergoing
- newly diagnosed
- ejection fraction
- left atrial appendage
- chronic kidney disease
- single molecule
- peritoneal dialysis
- heart failure
- mitral valve
- prognostic factors
- left ventricular
- direct oral anticoagulants
- risk factors
- percutaneous coronary intervention
- patient reported outcomes